Literature DB >> 18698171

IL-17 and the Th17 lineage in systemic lupus erythematosus.

Lee Ann Garrett-Sinha1, Shinu John, Sarah L Gaffen.   

Abstract

PURPOSE OF REVIEW: Systemic lupus erythematosus etiology includes both genetic and environmental factors. Evidence suggests that many genetic loci in humans and mouse models contribute to the occurrence and clinical presentation of lupus. This large array of different genes affects many aspects of immune cell function, including the activation and functional differentiation of B cells, T cells, dendritic cells and other immune cells. In particular, the T-cell components that contribute to systemic lupus erythematosus pathogenesis are incompletely defined. RECENT
FINDINGS: A major paradigm shift in understanding how CD4+ T cells contribute to autoimmunity recently occurred with the discovery of a new T-cell population that produces the cytokine IL-17 (IL-17A), termed 'Th17'. Although Th17 cells contribute to autoimmune disease in rheumatoid arthritis and Crohn's disease, their role in systemic lupus erythematosus is far less clear.
SUMMARY: In this review, we focus on an emerging role for the cytokine IL-17 and the cells that produce it in contributing to lupus in particular based on recent findings in animal models.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698171     DOI: 10.1097/BOR.0b013e328304b6b5

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  69 in total

1.  IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.

Authors:  Vinh Nguyen; Irina Luzina; Horea Rus; Cosmin Tegla; Ching Chen; Violeta Rus
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

Review 2.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

Review 3.  New and emerging therapies for acute and chronic graft versus host disease.

Authors:  LaQuisa Hill; Amin Alousi; Partow Kebriaei; Rohtesh Mehta; Katayoun Rezvani; Elizabeth Shpall
Journal:  Ther Adv Hematol       Date:  2017-11-28

4.  Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model.

Authors:  Y Zhu; Y Yue; S Xiong
Journal:  Clin Exp Immunol       Date:  2018-07-23       Impact factor: 4.330

5.  Vitamin D improves cognitive function and modulates Th17/T reg cell balance after hepatectomy in mice.

Authors:  Ayong Tian; Hong Ma; Xuezhao Cao; Rongwei Zhang; Xiaolong Wang; Binyang Wu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

6.  Detection of dynamic frequencies of Th17 cells and their associations with clinical parameters in patients with systemic lupus erythematosus receiving standard therapy.

Authors:  Zhenke Wen; Lin Xu; Wei Xu; Sidong Xiong
Journal:  Clin Rheumatol       Date:  2014-05-10       Impact factor: 2.980

7.  Th17 cells facilitate the humoral immune response in patients with acute viral myocarditis.

Authors:  Jing Yuan; Ai-Lin Cao; Miao Yu; Qiong-Wen Lin; Xian Yu; Jing-Hui Zhang; Min Wang; He-Ping Guo; Yu-Hua Liao
Journal:  J Clin Immunol       Date:  2009-12-10       Impact factor: 8.317

Review 8.  IL-17RC: a partner in IL-17 signaling and beyond.

Authors:  Allen W Ho; Sarah L Gaffen
Journal:  Semin Immunopathol       Date:  2009-12-13       Impact factor: 9.623

Review 9.  Interleukin-17 and systemic lupus erythematosus: current concepts.

Authors:  A Nalbandian; J C Crispín; G C Tsokos
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 10.  Emerging role of interleukin-22 in autoimmune diseases.

Authors:  Hai-Feng Pan; Xiang-Pei Li; Song Guo Zheng; Dong-Qing Ye
Journal:  Cytokine Growth Factor Rev       Date:  2012-08-18       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.